We would like to invite passionate advocates, health professionals, and health and advocacy organisations committed to advancing liver health to apply to join the EASL Global Liver Advocacy Network. Launching at EASL Congress 2025, this initiative will unite a global community dedicated to raisin…
(Geneva, 29 January) EASL strongly welcomes Ireland’s upcoming groundbreaking initiative to introduce comprehensive on-label health warnings for alcohol products and urges other countries to follow suit. Scheduled to commence in May 2026, these measures represent a rational step in increasing c…
EASL has published updated Clinical Practice Guidelines for Hepatocellular Carcinoma (HCC), providing practical recommendations rooted in the latest evidence. These guidelines aim to assist healthcare professionals in managing this complex disease with a patient-centered and multidisciplinary app…
11 December 2024 17:00 – 18:00 UTC Time Copenhagen, Denmark WHO/Europe, in collaboration with the European Association for the Study of the Liver (EASL), will host a European Alcohol Health Alliance Symposium, taking place in Copenhagen, Denmark, on 11 December 2024. This symposium offers a valu…
EMBARGO UNTIL 12.00 noon, Tuesday 3 December Photo opportunity: A giant, walking alcohol bottle will attend the launch of the exhibition. It will also meet MEP Andriukaitis during the official launch (around 18.00) at the European Parliament, Altiero Spinelli Building, Floor 3 – End of the Forum …
EASL has released its updated Clinical Practice Guidelines on Liver Transplantation (LT). The guidelines represent a significant overhaul, reflecting major advancements in the field since the last update in 2016. The field of liver transplantation (LT) has advanced significantly in recent years, …
The recipient of the 2024 Daniel Alagille Award, Sarina Shabso, discusses her inspiring journey into the field of hepatology. Shabso’s path, from her early focus on skin regeneration to her groundbreaking research on genetic cholestatic diseases, showcases her dedication and innovative spirit, wh…
In an insightful conversation with EASL, Scott Waddell, the recipient of the 2023 Daniel Alagille Award, shares his journey into the field of hepatology. From his initial focus on cholangiocarcinoma to his pioneering work on polycystic liver disease, Waddell’s dedication and innovative approach h…
The EMA human medicines committee (CHMP) has recently issued a statement on Obeticholic acid for the treatment of Primary Biliary Cholangitis (PBC). The CHMP recommended to the European Commission that the market authorisation for Obeticholic acid in the European Union (EU) be revoked (https://ww…
• First patient enrolled at Hôpital Beaujon, Clichy, France • The COMBAT Trial is a multicenter, randomized, open-label, Phase II clinical trial in patients with decompensated cirrhosis Barcelona, Spain, 9th July 2024 – DECISION, an EU-funded research consortium in liver disease research, is plea…
